BMJ 1996;313:407-411 (17 August)
Education and debate
Fortnightly Review: Neonatal screening for sickle cell disorders: what about the carrier infants?
Linda Laird,
senior registrar in public health medicine,a
Carol Dezateux,
senior lecturer in paediatric epidemiology,a
Elizabeth N Anionwu,
senior lecturer in community genetic counselling ba Department of Epidemiology and Biostatistics, Institute of Child Health, London WC1N 1EH,
b Department of Clinical Genetics and Fetal Medicine, Institute of Child Health
Correspondence to: Carol Dezateux.
|
Summary points
- Neonatal screening for sickle cell disorders detects between 17 and 100 carrier infants for each child detected as having sickle cell disorder
- Information on neonatal carrier status is an unavoidable outcome of the neonatal screening process
- Withholding information from parents is not justified
- Further research is needed to evaluate the benefits and risks of this information and the effectiveness of different policies for follow up
- This is relevant to future developments in molecular genetics, which may place health services under increasing pressure to test for a wide range of genetic conditions in early childhood
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Relevant Article
-
Infants in Sandwell are screened for haemoglobinopathy gene
- Jammi N Rao, Sunil I Handa, Penelope J Stableforth, Jackie Martin, Helen Watson, and Glenda Augustine
BMJ 1996 313: 1403.
[Extract]
[Full Text]
This article has been cited by other articles:
-
Ciske, D. J., Haavisto, A., Laxova, A., Rock, L. Z. M., Farrell, P. M.
(2001). Genetic Counseling and Neonatal Screening for Cystic Fibrosis: An Assessment of the Communication Process. Pediatrics
107: 699-705
[Abstract]
[Full text]
-
Farrell, M. H., Certain, L. K., Farrell, P. M.
(2001). Genetic Counseling and Risk Communication Services of Newborn Screening Programs. Arch Pediatr Adolesc Med
155: 120-126
[Abstract]
[Full text]